A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
dc.contributor.author | Okuno, Keisuke | |
dc.contributor.author | Kandimalla, Raju | |
dc.contributor.author | Mendiola, Marta | |
dc.contributor.author | Balaguer, Francesc | |
dc.contributor.author | Bujanda Fernández de Pierola, Luis ![]() | |
dc.contributor.author | Fernández Martos, Carlos | |
dc.contributor.author | Aparicio, Jorge | |
dc.contributor.author | Feliú, jaime | |
dc.contributor.author | Tokunaga, Masanori | |
dc.contributor.author | Kinugasa, Yusuke | |
dc.contributor.author | Maurel, Joan | |
dc.contributor.author | Goel, Ajay | |
dc.date.accessioned | 2023-02-20T17:44:56Z | |
dc.date.available | 2023-02-20T17:44:56Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Molecular Cancer 22 : (2023) // Article ID 13 | es_ES |
dc.identifier.issn | 1476-4598 | |
dc.identifier.uri | http://hdl.handle.net/10810/59988 | |
dc.description.sponsorship | The present work was supported by the CA72851, CA181572, CA184792, and CA187956 grants from the National Cancer Institute, National Institute of Health; RP140784 from the Cancer Prevention Research Institute of Texas; grants from the Sammons Cancer Center and Baylor Foundation, as well as funds from the Baylor Research Institute, Dallas, TX, USA awarded to Ajay Goel. The present work was also supported by Catalan Agency for Management of University and Research Grants (AGAUR) (2014-SGR-474 and 2017-SGR-1174), Fundació la Marató de TV3 (201330.10), Instituto de Salud Carlos III (PI13/01728 and PI19/00740) and Fundacion Olga Torres (Modalitat A. 2019/2020) to Joan Maurel. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | BMC | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | colorectal cancer | es_ES |
dc.subject | microRNA | es_ES |
dc.subject | predictive biomarker | es_ES |
dc.subject | adjuvant chemotherapy | es_ES |
dc.subject | FOLFOX | es_ES |
dc.title | A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | © The Author(s) 2023.This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-022-01699-2 | es_ES |
dc.identifier.doi | 10.1186/s12943-022-01699-2 | |
dc.departamentoes | Medicina | es_ES |
dc.departamentoeu | Medikuntza | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as © The Author(s) 2023.This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.